Yamaguchi T, Kawakami H, Sakai D, Kurokawa Y, et al. Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S - 1 therapy. BMC Cancer 2022;22:773.
PMID: 35840917